Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome. (Q33403059)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome. |
scientific article |
Statements
Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome (English)
Rami S Komrokji
Jeffrey E Lancet
Arlene S Swern
Nianhang Chen
Jennifer Paleveda
Richard Lush
Hussain I Saba
30 August 2012